Skip to content

Clinical trials

Phase 1 Osteoporosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 1 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20171
20192
20201
20221
20231
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed3
Not yet recruiting2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.2
Fujian Academy of Traditional Chinese Medicine1
GlaxoSmithKline1
HELP Therapeutics Co., Ltd.1
HJB (Hangzhou) Co., Ltd.1
Jiangsu T-Mab Biopharma Co.,Ltd1
Shenzhen Salubris Pharmaceuticals Co., Ltd.1
Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
The Affiliated Hospital of Qingdao University1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis11
Bone Resorption1
Fractures, Bone1
Osteoarthritis1
Osteoporosis, Postmenopausal1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.